ARFGEF3
Brefeldin A-inhibited guanine nucleotide-exchange protein 3
Also known as: BIG3, BIG3_HUMAN, C6orf92, dJ171N11.1, KIAA1244, PPP1R33
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5TH69
- Gene
- ARFGEF3
- Ensembl
- ENSG00000112379
- Chromosome
- 6
- Canonical length
- 2177 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Predicted to enable guanyl-nucleotide exchange factor activity. Predicted to be involved in regulation of ARF protein signal transduction. Predicted to be located in transport vesicle membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
2177 residues, UniProt reviewed canonical sequence.
>Q5TH69|ARFGEF3
1 MEEILRKLQK EASGSKYKAI KESCTWALET LGGLDTIVKI PPHVLREKCL LPLQLALESK
61 NVKLAQHALA GMQKLLSEER FVSMETDSDE KQLLNQILNA VKVTPSLNED LQVEVMKVLL
121 CITYTPTFDL NGSAVLKIAE VCIETYISSC HQRSINTAVR ATLSQMLSDL TLQLRQRQEN
181 TIIENPDVPQ DFGNQGSTVE SLCDDVVSVL TVLCEKLQAA INDSQQLQLL YLECILSVLS
241 SSSSSMHLHR RFTDLIWKNL CPALIVILGN PIHDKTITSA HTSSTSTSLE SDSASPGVSD
301 HGRGSGCSCT APALSGPVAR TIYYIAAELV RLVGSVDSMK PVLQSLYHRV LLYPPPQHRV
361 EAIKIMKEIL GSPQRLCDLA GPSSTESESR KRSISKRKSH LDLLKLIMDG MTEACIKGGI
421 EACYAAVSCV CTLLGALDEL SQGKGLSEGQ VQLLLLRLEE LKDGAEWSRD SMEINEADFR
481 WQRRVLSSEH TPWESGNERS LDISISVTTD TGQTTLEGEL GQTTPEDHSG NHKNSLKSPA
541 IPEGKETLSK VLETEAVDQP DVVQRSHTVP YPDITNFLSV DCRTRSYGSR YSESNFSVDD
601 QDLSRTEFDS CDQYSMAAEK DSGRSDVSDI GSDNCSLADE EQTPRDCLGH RSLRTAALSL
661 KLLKNQEADQ HSARLFIQSL EGLLPRLLSL SNVEEVDTAL QNFASTFCSG MMHSPGFDGN
721 SSLSFQMLMN ADSLYTAAHC ALLLNLKLSH GDYYRKRPTL APGVMKDFMK QVQTSGVLMV
781 FSQAWIEELY HQVLDRNMLG EAGYWGSPED NSLPLITMLT DIDGLESSAI GGQLMASAAT
841 ESPFAQSRRI DDSTVAGVAF ARYILVGCWK NLIDTLSTPL TGRMAGSSKG LAFILGAEGI
901 KEQNQKERDA ICMSLDGLRK AARLSCALGV AANCASALAQ MAAASCVQEE KEEREAQEPS
961 DAITQVKLKV EQKLEQIGKV QGVWLHTAHV LCMEAILSVG LEMGSHNPDC WPHVFRVCEY
1021 VGTLEHNHFS DGASQPPLTI SQPQKATGSA GLLGDPECEG SPPEHSPEQG RSLSTAPVVQ
1081 PLSIQDLVRE GSRGRASDFR GGSLMSGSSA AKVVLTLSTQ ADRLFEDATD KLNLMALGGF
1141 LYQLKKASQS QLFHSVTDTV DYSLAMPGEV KSTQDRKSAL HLFRLGNAML RIVRSKARPL
1201 LHVMRCWSLV APHLVEAACH KERHVSQKAV SFIHDILTEV LTDWNEPPHF HFNEALFRPF
1261 ERIMQLELCD EDVQDQVVTS IGELVEVCST QIQSGWRPLF SALETVHGGN KSEMKEYLVG
1321 DYSMGKGQAP VFDVFEAFLN TDNIQVFANA ATSYIMCLMK FVKGLGEVDC KEIGDCAPAP
1381 GAPSTDLCLP ALDYLRRCSQ LLAKIYKMPL KPIFLSGRLA GLPRRLQEQS ASSEDGIESV
1441 LSDFDDDTGL IEVWIILLEQ LTAAVSNCPR QHQPPTLDLL FELLRDVTKT PGPGFGIYAV
1501 VHLLLPVMSV WLRRSHKDHS YWDMASANFK HAIGLSCELV VEHIQSFLHS DIRYESMINT
1561 MLKDLFELLV ACVAKPTETI SRVGCSCIRY VLVTAGPVFT EEMWRLACCA LQDAFSATLK
1621 PVKDLLGCFH SGTESFSGEG CQVRVAAPSS SPSAEAEYWR IRAMAQQVFM LDTQCSPKTP
1681 NNFDHAQSCQ LIIELPPDEK PNGHTKKSVS FREIVVSLLS HQVLLQNLYD ILLEEFVKGP
1741 SPGEEKTIQV PEAKLAGFLR YISMQNLAVI FDLLLDSYRT AREFDTSPGL KCLLKKVSGI
1801 GGAANLYRQS AMSFNIYFHA LVCAVLTNQE TITAEQVKKV LFEDDERSTD SSQQCSSEDE
1861 DIFEETAQVS PPRGKEKRQW RARMPLLSVQ PVSNADWVWL VKRLHKLCME LCNNYIQMHL
1921 DLENCMEEPP IFKGDPFFIL PSFQSESSTP STGGFSGKET PSEDDRSQSR EHMGESLSLK
1981 AGGGDLLLPP SPKVEKKDPS RKKEWWENAG NKIYTMAADK TISKLMTEYK KRKQQHNLSA
2041 FPKEVKVEKK GEPLGPRGQD SPLLQRPQHL MDQGQMRHSF SAGPELLRQD KRPRSGSTGS
2101 SLSVSVRDAE AQIQAWTNMV LTVLNQIQIL PDQTFTALQP AVFPCISQLT CHVTDIRVRQ
2161 AVREWLGRVG RVYDIIVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ARFGEF3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 20 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 20 nTPM
- salivary gland: 17 nTPM
- parathyroid gland: 15 nTPM
- cerebral cortex: 13 nTPM
- prostate: 11 nTPM
- spinal cord: 10 nTPM
Single-cell type
- prostatic glandular cells: 626 nCPM
- somatotrophs: 611 nCPM
- salivary acinar cells: 548 nCPM
- pancreatic islet cells: 490 nCPM
- alveolar cells type 2: 482 nCPM
- oligodendrocytes: 481 nCPM
Immune cell
- basophil: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- white matter: 88 nTPM
- cerebellum: 74 nTPM
- midbrain: 71 nTPM
- cerebral cortex: 68 nTPM
- hippocampal formation: 66 nTPM
- basal ganglia: 65 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.2
- gnomAD pLI
- 1
- DepMap mean gene effect
- 0.09
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ARFGEF3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ARFGEF3 as an antibody target. Whether an autoantibody or antibody against ARFGEF3 could matter depends on whether native ARFGEF3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ARFGEF3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ARFGEF3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...